Log In

 

Company Name : Boehringer Ingelheim

Sunday, February 18, 2018 1:59PM IST (8:29AM GMT)

(BW)(BOEHRINGER-INGELHEIM)

Systemic Sclerosis World Congress: Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease


Ingelheim, Germany

  • 'More Than Scleroderma: The Inside Story' provides real-life stories and education about the life-threatening disease
  • New and truly inspiring patient stories are revealed
  • Help raise awareness of this little-known disease by visiting www.morethanscleroderma.com
  • “I’ve learned how to cope with this disease. There are many important things which I am still capable of doing.”– Anna, 36, living with scleroderma

Boehringer Ingelheim unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com.

 

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/

 
Anna, 36, living with scleroderma (Photo: Business Wire)

Anna, 36, living with scleroderma (Photo: Business Wire)

The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S.

 

The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact of the disease.

 

Anna, from Szombathely in Hungary, has shared her story on the website. She wants to encourage and inspire others with the disease: “I would like to make it clear to others that they are not alone.”

 

Anna, 36, recalls how “Back when I was originally diagnosed, my world completely fell apart…I found everything terrifying.” She didn’t know anyone else with the disease and couldn’t find positive stories. But Anna learned how to cope with the disease, and after a difficult journey she is happy again and enjoying life. “Today I’m much more grateful for the little things,” she explains.

 

To see Anna’s story and those of other patients from around the world, visit www.morethanscleroderma.com and https://www.boehringer-ingelheim.com/respiratory/systemic-sclerosis/inside-story

 

Scleroderma is a rare and potentially fatal disease involving the skin, lungs and other organs.1,2 It typically affects women in the prime of their lives, like Anna, between the ages of 25 and 55.3,4 Most people with the disease will develop some degree of lung scarring, or interstitial lung disease (ILD).1,5,6,7 Currently, there are no approved medicines for treating lung fibrosis associated with scleroderma.

 

FESCA Seeks Supportive Action

 

Annelise Rønnow, President of FESCA (The Federation of European Scleroderma Associations) values the opportunity for broad audiences to engage in raising awareness of this rare disease.

 

“Better awareness of scleroderma and its signs and symptoms should help people get diagnosed earlier, so care and support can be provided,” said Annelise Rønnow. “It is so inspiring and insightful to hear the poignant journeys of people living with the disease. We support ‘More Than Scleroderma: The Inside Story’, for the information and help it can offer people affected by this little-known disease”.

 

~ ENDS ~

 

Please click on the link below for ‘Notes to Editors’ and ‘References’:

 

http://www.boehringer-ingelheim.com/press-release/systemic-sclerosis-world-congress

 

Intended audiences:

 

This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business.

 

 

 

 
MULTIMEDIA AVAILABLE :
http://www.businesswire.com/news/home/20180216005188/en/


Click here for Media Contact Details
CONTACTS :

Boehringer Ingelheim
Corporate Communications
Media + PR
Dr. Kristin Jakobs
Phone: +49 6132 – 77 144553
Fax: +49 6132 – 77 6601
Email: press@boehringeringelheim.com


More News from Boehringer Ingelheim

15/12/2018 8:53PM

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer

Results from a real-world study1 support a recent update to the ESMO guidelines2 recommending nintedanib (Vargatef®) plus docetaxel following first-line chemotherapy (+/- immunotherapy) in ...

27/11/2018 1:38PM

American College of Cardiology recommends empagliflozin as preferred SGLT2 inhibitor for adults with type 2 diabetes and established cardiovascular disease in new Expert Consensus Decision Pathway

A new Expert Consensus Decision Pathway issued by the American College of Cardiology (ACC) recommends empagliflozin as the preferred SGLT2 inhibitor for its proven benefit in reducing the risk of cardiovascular death in ...

16/11/2018 1:10PM

Boehringer Ingelheim and Epizyme Announce Worldwide Collaboration to Develop Novel Epigenetic Oncology Therapies

Boehringer Ingelheim Expands Biomarker-driven Oncology Programs Alliance EnhancesEpizyme’s Leadership in Oncology Epigenetics Boehringer Ingelheim and Epizyme, Inc. (Nasdaq: EPZM) announced a new ...

Similar News

15/12/2018 8:53PM

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer

Results from a real-world study1 support a recent update to the ESMO guidelines2 recommending nintedanib (Vargatef®) plus docetaxel following first-line chemotherapy (+/- immunotherapy) in ...

No Image

15/12/2018 6:29PM

GSMA’s Programme ‘Tech4Girls’ Wins 2018 Corporate Citizen of the Americas Award from the Organization of American States

The Trust for the Americas has selected GSMA as a winner of the 2018 Corporate Citizen of the Americas Award in the category ‘Technical Skills for the Future of Work’ for its program ...